Link
- Argentinean Network of Women Living with HIV-AIDS
- Asia Pacific Network of People Living with HIV/AIDS
- bilaterals.org
- Cambodian People Living with HIV/AIDS Network (CPN+)
- Delhi Network of Positive People (DNP+)
- Essentialdrugs.org
- FACEBOOK PAGE: Stop the EU India Free Trade Agreement
- FTA Malaysia
- Health Action International – Asia Pacific
- Intellectual Property Watch
- Lawyers Collective HIV/AIDS Unit
- MSF Access Campaign
- National Association of People Living with HIV and AIDS in Nepal (NAPN)
- Public Citizen
- Stop Peru FTA
- Thai Network of People Living with HIV/Aids (TNP+)
- Third World Network
Take Action
Archives
-
Recent Posts
- The Cost of Price: Why and How to Get Beyond Intellectual Property Internalism
- WHA 65 adopted the resolution for way forward on CEWG report on R&D
- Corporations Win Big in Battle Against Investment Regulation
- US and EU Derailing Ten-year Process to Create Health Research & Development Convention
- MSF: Update on debates at World Health Assembly on a possible R&D convention, 23 May 2012
Categories
Monthly Archives: February 2012
Farmers’ Fight Of China FTA Could Be Biggest Yet
Source: www.wsj.com Farmers disrupt a public hearing on the South Korea-China free trade agreement, which was being held last Friday at the Coex convention center in Seoul. When South Korea started to negotiate a free trade agreement with the United … Continue reading
Posted in EU-Korea FTA, FTAs
Leave a comment
African IP Forum Postponed
The US Department of Commerce has announced it will postpone the controversial Africa IP Forum, and that “all stakeholders – in government, private business, the arts and the development community – are represented and engaged in the conference organization and … Continue reading
Posted in IP Rights
Leave a comment
New Novartis Supreme Court Date and Response to Novartis argumentation
UPDATE: India’s Supreme Court today decided to re-schedule the final hearing of the Novartis vs. the Government of India case for 28 March 2012. The hearings were initially scheduled to start today (28 February), but the Mumbai terror attack trial … Continue reading
Bill C-398 to fix Canada’s law on compulsory licensing for export – 2 media items
February 22, 2012 Source: EMBASSY Magazine Another chance on access to medicines By Richard Elliott Every day, people in the so-called global South are suffering and dying from treatable illness because of high medicine prices and limited resources. When we … Continue reading
Posted in access to medicines, Generic drug, HIV/Aids, TB
Leave a comment
End the India-EU free trade talks
Monday, February 27, 2012 Source: www.thedailystar.net Rolls Royce, Mercedes-Benz and BMW cars to get cheaper for Indian millionaires? Premium Scotch whisky brands set to become more “affordable,” with import duty reduction from 150% to just 60%? More European cheese to … Continue reading
Posted in access to medicines
Leave a comment
What’s (still) wrong with ACTA, and why governments should reject the illegitimate agreement
Source: Knowledge Ecology International ACTA is an attempt to bypass multilateral institutions Negotiations on ACTA were formerly announced on October 23, 2007. The ACTA announcement came less than three weeks after the World Intellectual Property Organization (WIPO) adopted the “Development Agenda,” … Continue reading
Posted in ACTA, IP Rights
Leave a comment
Novartis launches renewed attack on India’s right to produce affordable medicines
23-Feb-2012 In 2006, Swiss pharmaceutical giant Novartis launched a legal battle challenging India’s adoption of strict standards used to regulate patents on medicines. They argued that Section 3(d) of the recently amended Patents Act was ‘unconstitutional and violated international standards’ … Continue reading
Posted in Indian Patent Law, patent evergreening, Sec 3 (d)
Leave a comment
Update from India: Novartis Vs Government of India
The Novartis case is likely to be delayed from 28 February to March (date yet to be announced) due to the Mumbai terror attack trial running late in the Supreme Court. In addition, Court recess for Holi festival is scheduled … Continue reading
UPDATE: NOVARTIS ANNUAL SHAREHOLDERS MEETING: 23 February 2012
As shareholders of Swiss pharmaceutical company Novartis met today in Basel. Novartis offices saw a lot of action. Health, HIV and public interest organizations in New York, Washington DC, Boston and in Basel itself protested in front of the Novartis … Continue reading
Posted in access to medicines, Indian Patent Law, Novartis Case, patent evergreening, Sec 3 (d)
Tagged Imatinib, Novartis
Leave a comment
Novartis seeks predictable interpretation of law in high octane Indian Glivec case
22 February 2012 14:43 The crucial Indian patent case concerning Novartis’ anticancer Glivec (imatinib mesylate) and its rejection due to Section 3(d), a controversial provision in India’s patent law, comes up for hearing next week, amid hope and concern for … Continue reading
